4.16 USD
▼-0.11-2.58%
盘后 4.19 +0.72%
2026-11-19
市值
$1.51B
市盈率
62.08
EPS
0.07
股息率
—
52 周区间
3.04 – 8.98
成交量
4.37M
Beta
0.98
目标价
13.67
52W 低 3.0452W 高 8.98
价格走势
公司简介
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops pro...